SCHEMBL26833681

SCHEMBL26833681

c1ccc2cc(-c3ccc4c(ccc5cc(N(c6ccc(-c7ccc8c(cnc9ccccc98)n7)cc6)c6ccc(-c7ccc8c(cnc9ccccc98)n7)cc6)ccc54)c3)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.40
▸ GPR3 P46089 1/20 0.40
▸ NPC1 O15118 7/20 0.37
▸ MAPT P10636 4/20 0.37
▸ RAB9A P51151 6/20 0.36
▸ SMN1; SMN2 Q16637 5/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ NFKB1 P19838 2/20 0.36
▸ NFKB2 Q00653 2/20 0.36
▸ RELA Q04206 2/20 0.36
▸ PIK3CD O00329 3/20 0.36
▸ PIK3CA P42336 3/20 0.36
▸ MTOR P42345 2/20 0.36
▸ PIK3CB P42338 1/20 0.36
▸ PIK3CG P48736 1/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ AR P10275 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26833600 0.88 KDM4E (0.47) KDM4EGPR3NPC1MAPTRAB9A
SCHEMBL26833595 0.88 SRC (0.39) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL26833488 0.88 NPC1 (0.49) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL26833459 0.88 NPC1 (0.48) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL26833679 0.87 CYP3A4 (0.47) KDM4ENPC1MAPTRAB9ACYP3A4
SCHEMBL26833658 0.86 KDM4E (0.41) KDM4EGPR3NPC1MAPTRAB9A
SCHEMBL26833592 0.86 KDM4E (0.49) KDM4EGPR3PIK3CDPIK3CAMTOR
SCHEMBL26833481 0.85 NPC1 (0.47) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL26833695 0.84 KDM4E (0.37) KDM4EGPR3NPC1MAPTRAB9A
SCHEMBL26833448 0.83 PDGFRB (0.50) NPC1RAB9APIK3CDPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 KDM4E 3942/4885GPR3 8/4885NPC1 2396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback